Evolus (EOLS) Cost of Revenue (2019 - 2026)
Evolus' (EOLS) quarterly Cost of Revenue came in at $24.2 million in Q1 2026, up 10.85% YoY from $21.9 million in Q1 2025, and down 21.83% on a QoQ basis from $31.0 million in Q4 2025.
Evolus (EOLS) Cost of Revenue (2019 - 2026) Analysis & Trends
Evolus (EOLS) has 8 years of Cost of Revenue data on file, last reported at $24.2 million in Q1 2026.
- Quarterly Cost of Revenue rose 10.85% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.4 million (up 17.74% YoY) and the FY2025 annual result came in at $100.1 million, up 19.17% from the prior year.
- Cost of Revenue declined to $24.2 million in Q1 2026, from $31.0 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $31.0 million in Q4 2025 to a low of $12.1 million in Q1 2023.
- A 5-year average of $19.5 million and a median of $19.0 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue soared 169.11% — and 2023, when it fell 8.04%.
- Tracing EOLS's Cost of Revenue over 5 years: stood at $16.3 million in 2022, then jumped by 36.14% to $22.2 million in 2023, then advanced by 18.39% to $26.3 million in 2024, then grew by 17.85% to $31.0 million in 2025, then decreased by 21.83% to $24.2 million in 2026.
- The last three Cost of Revenue figures came in at $24.2 million (Q1 2026), $31.0 million (Q4 2025), and $23.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 26.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.90 Mn |
| Jun 30, 2026 | 26.90 Mn |
| Mar 31, 2026 | 24.24 Mn |
| Mar 31, 2026 | 24.24 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Sep 30, 2025 | 23.13 Mn |
| Sep 30, 2025 | 23.13 Mn |
| Jun 30, 2025 | 24.07 Mn |
| Jun 30, 2025 | 24.07 Mn |
| Mar 31, 2025 | 21.87 Mn |
| Mar 31, 2025 | 21.87 Mn |
| Dec 31, 2024 | 26.31 Mn |
| Dec 31, 2024 | 26.31 Mn |
| Sep 30, 2024 | 18.99 Mn |
| Sep 30, 2024 | 18.99 Mn |
| Jun 30, 2024 | 19.84 Mn |
| Jun 30, 2024 | 19.84 Mn |
| Mar 31, 2024 | 18.83 Mn |
| Mar 31, 2024 | 18.83 Mn |